This all-encompassing guide investigates the smart insulin pen and its influence on diabetes management. Here's what you need ...

Insulclock CAP, which received EU approval in 2018, assists users in detecting and avoiding errors in insulin administration.

Eli Lilly has unveiled a new partnership with diabetes device maker Dexcom to breathe new life into its diabetes division. The deal will see Dexcom's continuous glucose monitors integrated into ...

Insulcloud today announced its strategic expansion into the U.S. following FDA clearance for its Insulclock CAP smart device.

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

Marlaina Goedel, diagnosed at age 5, said she is no longer on insulin. For Dr. Daniel Gilada, a husband, physician and soon-to-be father of four, living with Type 1 diabetes had become “overwhelming.” ...

“Notably, glucose values vary over a narrow range (from approximately 2 to 20-30 mM [36 mg/dL to 360-540 mg/dL] in people with diabetes), so a rather steep change in insulin bioactivity must be ...

These findings may usher in a new era in diabetes treatment without the need for constant blood glucose monitoring, and insulin dosage comprises the foremost shortcomings of present therapies.

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...

Results from a very small study suggest that a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could help erase the need for insulin in folks with Type 2 diabetes.

Vienna — Participants with type 2 diabetes who were able to stop insulin for up to 12 months after receiving the novel recellularization via electroporation therapy (ReCET) procedure in ...

While an FDA advisory committee saw signals of efficacy for Lexicon Pharmaceuticals’ sotagliflozin, the panel of external ...